VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.

Javier Díaz-Alonso,Juan Paraíso-Luna,Carmen Navarrete,Carmen del Río,Irene Cantarero,Belén Palomares,José Aguareles,Javier Fernández-Ruiz,María L. Bellido,Federica Pollastro,Giovanni Appendino,Marco A. Calzado,Ismael Galve-Roperh,Eduardo Muñoz

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.

2016

Javier Díaz-Alonso
Juan Paraíso-Luna
Carmen Navarrete
Carmen del Río
Irene Cantarero
Belén Palomares
José Aguareles
Javier Fernández-Ruiz
María L. Bellido
Federica Pollastro
Giovanni Appendino
Marco A. Calzado
Ismael Galve-Roperh
Eduardo Muñoz

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease

Keywords:

Cannabigerol
Progenitor cell
Neural stem cell
Huntington's disease
Cellular differentiation
Mesenchymal stem cell
HEK 293 cells
Pharmacology
Cancer research
Cell culture
Biology
Neurodegeneration
Quinolinic acid
Cannabinoid
Huntingtin
Cannabinoid receptor
Neuroprotection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations